China's Tongjitang Mulls Merger Proposal
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - New York-listed Tongjitang Chinese Medicines took one step closer to privatization last week, when it put together a special committee to evaluate a merger proposal from its two largest shareholders